184 related articles for article (PubMed ID: 24990217)
1. Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer.
Wang Y; Li D; Li X; Teng C; Zhu L; Cui B; Zhao Y; Hu F
Med Oncol; 2014 Jul; 31(7):39. PubMed ID: 24990217
[TBL] [Abstract][Full Text] [Related]
2. Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population.
Hu F; Li D; Wang Y; Yao X; Zhang W; Liang J; Lin C; Ren J; Zhu L; Wu Z; Li S; Li Y; Zhao X; Cui B; Dong X; Tian S; Zhao Y
PLoS One; 2013; 8(4):e60233. PubMed ID: 23573243
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India.
Malhotra P; Anwar M; Kochhar R; Ahmad S; Vaiphei K; Mahmood S
Tumour Biol; 2014 Apr; 35(4):3679-87. PubMed ID: 24317816
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorectal cancer.
Zhang R; Qin W; Xu GL; Zeng FF; Li CX
Colorectal Dis; 2012 Mar; 14(3):e80-9. PubMed ID: 21988782
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.
Li M; Zhao ZW
Med Oncol; 2012 Jun; 29(2):970-6. PubMed ID: 21660619
[TBL] [Abstract][Full Text] [Related]
7. Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China.
Li G; Hu F; Yuan F; Fan J; Yu Z; Wu Z; Zhao X; Li Y; Li S; Rong J; Cui B; Dong X; Yuan H; Zhao Y
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1393-404. PubMed ID: 25560462
[TBL] [Abstract][Full Text] [Related]
8. The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population.
Christensen LL; Madsen BE; Wikman FP; Wiuf C; Koed K; Tjønneland A; Olsen A; Syvänen AC; Andersen CL; Orntoft TF
BMC Med Genet; 2008 Jun; 9():52. PubMed ID: 18547406
[TBL] [Abstract][Full Text] [Related]
9. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
[TBL] [Abstract][Full Text] [Related]
10. [Study of germline mutation of hMSH2, hMSH6 and hMLH1 and methylation of hMLH1 in microsatellite instability colorectal cancer].
Ni M; Jin HY; Ding YJ; Liu F; Ding SQ; Fan ZM; Wang YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):358-61. PubMed ID: 18636359
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.
Wang Y; Li G; Hu F; Bi H; Wu Z; Zhao X; Li Y; Li S; Li D; Cui B; Dong X; Zhao Y
Med Oncol; 2014 Jun; 31(6):975. PubMed ID: 24793746
[TBL] [Abstract][Full Text] [Related]
12. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
[TBL] [Abstract][Full Text] [Related]
14. Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers.
Yuen ST; Chan TL; Ho JW; Chan AS; Chung LP; Lam PW; Tse CW; Wyllie AH; Leung SY
Oncogene; 2002 Oct; 21(49):7585-92. PubMed ID: 12386821
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G
Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.
Li D; Hu F; Wang F; Cui B; Dong X; Zhang W; Lin C; Li X; Wang D; Zhao Y
PLoS One; 2013; 8(3):e51240. PubMed ID: 23526924
[TBL] [Abstract][Full Text] [Related]
17. hMLH1 and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients.
Kámory E; Kolacsek O; Ottó S; Csuka O
Pathol Oncol Res; 2003; 9(4):236-41. PubMed ID: 14688830
[TBL] [Abstract][Full Text] [Related]
18. Absence of hMLH1 or hMSH2 expression as a stage-dependent prognostic factor in sporadic colorectal cancers.
Park JW; Chang HJ; Park S; Kim BC; Kim DY; Baek JY; Kim SY; Oh JH; Choi HS; Park SC; Jeong SY
Ann Surg Oncol; 2010 Nov; 17(11):2839-46. PubMed ID: 20549564
[TBL] [Abstract][Full Text] [Related]
19. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability.
Bevilacqua RA; Simpson AJ
Int J Cancer; 2000 Jul; 87(2):200-3. PubMed ID: 10861474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
